• Latest Posts

Pieris Pharma: is it worth going to NASDAQ for only €31 Million?

[Update] AstraZeneca to buy a CAR-T expert?

Immuno-oncology race gets bloodier: BMS is suing its former executive now working for AstraZeneca

Pfizer to Control Cellectis in a €1.5 Billion Deal?

PsiOxus raised €34.7 Million from First-Class investors

European Union supports Bavarian Nordic to cure Ebola


Eli Lilly signs a €250M deal with BioNTech for new Cancer Immunotherapies

Sanofi and Selecta will develop a “Negative Vaccine” for Celiac Disease

[UPDATE] Adaptimmune raised €156.7M in its IPO

US-based Juno Therapeutics purchased a German biotech

Natural Killer therapies for Cancer: a Fast-Evolving field

Another Partnership between Immunocore and MedImmune against Skin Cancer